Functional Repair of CFTR by CRISPR/Cas9 in Intestinal Stem Cell Organoids of Cystic Fibrosis Patients

Schwank, Gerald, Koo, Bon-Kyoung, Sasselli, Valentina, Dekkers, Johanna F., Heo, Inha, Demircan, Turan, Sasaki, Nobuo, Boymans, Sander +5 more·2013·Cell Stem Cell

Cited by (1,001)

Items 101–200 of 1,001

  1. Organoid Models of Human Gastrointestinal Development and Disease
    Priya H. Dedhia, Nina Bertaux‐Skeirik, Yana L. Zavros, Jason R. Spence · 2016 · Gastroenterology
  2. Correction of a genetic disease by CRISPR-Cas9-mediated gene editing in mouse spermatogonial stem cells
    Wu, Yuxuan, Zhou, Hai, Fan, Xiaoying, Zhang, Ying, Zhang, Man, Wang, Yinghua, Xie, Zhenfei, Bai, Meizhu, Yin, Qi, Liang, Dan et al. · 2015 · Cell Research
  3. Engineering human tumour-associated chromosomal translocations with the RNA-guided CRISPR–Cas9 system
    Raúl Torres-Ruiz, Marina Carrasco Martin, Angie Fernanda Rodriguez Garcia, Juan C. Cigudosa, Juan Carlos Ramı́rez, Sandra Rodríguez · 2014 · Nature Communications
  4. What is CRISPR/Cas9?
    Redman, Melody, King, Andrew, Watson, Caroline, King, David · 2016 · Archives of disease in childhood - Education & practice edition
  5. CRISPR-mediated Genome Editing Restores Dystrophin Expression and Function in mdx Mice
    Xu, Li, Park, Ki Ho, Zhao, Lixia, Xu, Jing, El Refaey, Mona, Gao, Yandi, Zhu, Hua, Ma, Jianjie, Han, Renzhi · 2016 · Molecular Therapy
  6. High-throughput and all-solution phase African Swine Fever Virus (ASFV) detection using CRISPR-Cas12a and fluorescence based point-of-care system
    Qian He, Dongmei Yu, Mengdi Bao, Grant Korensky, Juhong Chen, Mingyeong Shin, Juwon Kim, Myeongkee Park, Peiwu Qin, Ke Du · 2020 · Biosensors and Bioelectronics
  7. Transplantation of engineered organoids enables rapid generation of metastatic mouse models of colorectal cancer
    Kevin P. O’Rourke, Evangelia Loizou, Geulah Livshits, Emma M. Schatoff, Timour Baslan, Eusebio Manchado, Janelle M. Simon, Paul Bernard Romesser, Benjamin I. Leach, Teng Han et al. · 2017 · Nature Biotechnology
  8. The rapidly evolving view of lysosomal storage diseases
    Parenti, Giancarlo, Medina, Diego L, Ballabio, Andrea · 2021 · EMBO Molecular Medicine
  9. Genome editing with the CRISPR‐Cas system: an art, ethics and global regulatory perspective
    Debin Zhang, Amjad Hussain, Hakim Manghwar, Kabin Xie, Shengsong Xie, Shuhong Zhao, Robert M. Larkin, Ping Qing, Shuangxia Jin, Fang Ding · 2020 · Plant Biotechnology Journal
  10. CRISPR-Cas9 delivery to hard-to-transfect cells via membrane deformation
    Xin Han, Zongbin Liu, Myeong Chan Jo, Kai Zhang, Ying Li, Zihua Zeng, Nan Li, Youli Zu, Lidong Qin · 2015 · Science Advances
  11. A CRISPR view of development
    Melissa M. Harrison, Brian Jenkins, Kate M. O’Connor-Giles, Jill Wildonger · 2014 · Genes & Development
  12. Retinal stem cell transplantation: Balancing safety and potential
    Mandeep S. Singh, Susanna S. Park, Thomas Arno Albini, M. Valeria Canto-Soler, Henry J. Klassen, Robert Edward MacLaren, Masayo Takahashi, Aaron Nagiel, Steven D. Schwartz, Kapil Bharti · 2019 · Progress in Retinal and Eye Research
  13. Macrophage-Specific in Vivo Gene Editing Using Cationic Lipid-Assisted Polymeric Nanoparticles
    Ying‐Li Luo, Cong‐Fei Xu, Hongjun Li, Zhiting Cao, Jing Liu, Jilong Wang, Xiao‐Jiao Du, Xianzhu Yang, Zhen Gu, Jun Wang · 2018 · ACS Nano
  14. CRISPR-Based Adenine Editors Correct Nonsense Mutations in a Cystic Fibrosis Organoid Biobank
    Geurts, Maarten H., de Poel, Eyleen, Amatngalim, Gimano D., Oka, Rurika, Meijers, Fleur M., Kruisselbrink, Evelien, van Mourik, Peter, Berkers, Gitte, de Winter-de Groot, Karin M., Michel, Sabine et al. · 2020 · Cell Stem Cell
  15. Pooled In Vitro and In Vivo CRISPR-Cas9 Screening Identifies Tumor Suppressors in Human Colon Organoids
    Michels, Birgitta E., Mosa, Mohammed H., Streibl, Barbara I., Zhan, Tianzuo, Menche, Constantin, Abou-El-Ardat, Khalil, Darvishi, Tahmineh, Członka, Ewelina, Wagner, Sebastian, Winter, Jan et al. · 2020 · Cell Stem Cell
  16. Principles, Applications, and Biosafety of Plant Genome Editing Using CRISPR-Cas9
    Kaoutar El‐Mounadi, María Luisa Morales-Floriano, Hernán García-Ruíz · 2020 · Frontiers in Plant Science
  17. Bioengineering Approaches for the Advanced Organoid Research
    Yi, Sang Ah, Zhang, Yixiao, Rathnam, Christopher, Pongkulapa, Thanapat, Lee, Ki‐Bum · 2021 · Advanced Materials
  18. Stem cell-derived organoids and their application for medical research and patient treatment
    Sina Bartfeld, Hans C. Clevers · 2017 · Journal of Molecular Medicine
  19. Probing the Tumor Suppressor Function of BAP1 in CRISPR-Engineered Human Liver Organoids
    Artegiani, Benedetta, van Voorthuijsen, Lisa, Lindeboom, Rik G.H., Seinstra, Daniëlle, Heo, Inha, Tapia, Pablo, López-Iglesias, Carmen, Postrach, Daniel, Dayton, Talya, Oka, Rurika et al. · 2019 · Cell Stem Cell
  20. 3D cell culture models: Drug pharmacokinetics, safety assessment, and regulatory consideration
    Hongbing Wang, Paul C. Brown, Edwin C.Y. Chow, Lorna C. Ewart, Stephen Ferguson, Suzanne Fitzpatrick, Benjamin Freedman, Grace Liejun Guo, William D. Hedrich, Scott A. Heyward et al. · 2021 · Clinical and Translational Science
  21. Modeling Pancreatic Cancer with Organoids
    Lindsey A. Baker, Hervé Tiriac, Hans C. Clevers, David Arthur Tuveson · 2016 · Trends in cancer
  22. Mini-Gut Organoids: Reconstitution of the Stem Cell Niche
    Shoichi Date, Toshiro Sato · 2015 · Annual Review of Cell and Developmental Biology
  23. RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation
    Helen H N Yan, Jeffrey C W Lai, Siu Lun Ho, Wai K. Leung, Wai Lun Law, Janet F. Y. Lee, Anthony K W Chan, Wai Yin Tsui, Annie S.Y. Chan, Bernard C. H. Lee et al. · 2016 · Gut
  24. Organoids for Drug Discovery and Personalized Medicine
    Toshio Takahashi · 2018 · The Annual Review of Pharmacology and Toxicology
  25. CRISPR-Cas9: a new and promising player in gene therapy
    Xiao-Jie, Lu, Hui-Ying, Xue, Zun-Ping, Ke, Jin-Lian, Chen, Li-Juan, Ji · 2015 · Journal of Medical Genetics
  26. Strategies for nonviral nanoparticle‐based delivery of CRISPR/Cas9 therapeutics
    Chen, Fengqian, Alphonse, Martin, Liu, Qi · 2020 · WIREs Nanomedicine and Nanobiotechnology
  27. CRISPR-Cas9-Mediated Single-Gene and Gene Family Disruption in Trypanosoma cruzi
    Duo Peng, Samarchith P. Kurup, Phil Y. Yao, Todd A. Minning, Rick L. Tarleton · 2014 · mBio
  28. Use and application of 3D-organoid technology
    Benedetta Artegiani, Hans C. Clevers · 2018 · Human Molecular Genetics
  29. Gene editing and CRISPR in the clinic: current and future perspectives
    Matthew P. Hirakawa, Raga Krishnakumar, Jerilyn A. Timlin, James P. Carney, Kimberly S. Butler · 2020 · Bioscience Reports
  30. CRISPR-Cas Tools and Their Application in Genetic Engineering of Human Stem Cells and Organoids
    Delilah F. G. Hendriks, Hans C. Clevers, Benedetta Artegiani · 2020 · Cell stem cell
  31. Regenerative Reprogramming of the Intestinal Stem Cell State via Hippo Signaling Suppresses Metastatic Colorectal Cancer
    Priscilla Cheung, Jordi Xiol, Michael T. Dill, Wei-Chien Yuan, Riccardo Panero, Jatin Roper, Fernando G. Osorio, Dejan Maglic, Qi Li, Basanta Gurung et al. · 2020 · Cell stem cell
  32. A mouse model for adult cardiac-specific gene deletion with CRISPR/Cas9
    Kelli J. Carroll, Catherine A. Makarewich, John McAnally, Douglas M. Anderson, Lorena Zentilin, Ning Liu, Mauro Giacca, Rhonda Bassel‐Duby, Eric N. Olson · 2015 · Proceedings of the National Academy of Sciences
  33. Precision genome editing in the CRISPR era
    Jayme Salsman, Graham Dellaire · 2016 · Biochemistry and Cell Biology
  34. Human enteroids as an <i>ex-vivo</i> model of host–pathogen interactions in the gastrointestinal tract
    Foulke-Abel, Jennifer, In, Julie, Kovbasnjuk, Olga, Zachos, Nicholas C, Ettayebi, Khalil, Blutt, Sarah E, Hyser, Joseph M, Zeng, Xi-Lei, Crawford, Sue E, Broughman, James R et al. · 2014 · Experimental Biology and Medicine
  35. Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells
    Beatrice Xuan Ho, Nicole Min Qian Pek, Boon-Seng Soh · 2018 · International Journal of Molecular Sciences
  36. Development of CRISPR-Cas systems for genome editing and beyond
    F. Zhang · 2019 · Quarterly Reviews of Biophysics
  37. Insert, remove or replace: A highly advanced genome editing system using CRISPR/Cas9
    Stanislaus Antony Ceasar, Vinothkumar Rajan, Sergey V. Prykhozhij, Jason N. Berman, Savarimuthu Ignacimuthu S.J. · 2016 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  38. Organoid culture systems to study host–pathogen interactions
    Devanjali Dutta, Hans C. Clevers · 2017 · Current Opinion in Immunology
  39. CRISPR/Cas9 Immune System as a Tool for Genome Engineering
    Magdalena Hryhorowicz, Daniel Lipiński, Joanna Zeyland, Ryszard Słomski · 2016 · Archivum Immunologiae et Therapiae Experimentalis
  40. CRISPR/Cas9‐mediated somatic correction of a novel coagulator factor IX gene mutation ameliorates hemophilia in mouse
    Yuting Guan, Yanlin Ma, Qi Li, Zhenliang Sun, Lie Ma, Lijuan Wu, Liren Wang, Li Zeng, Yanjiao Shao, Yuting Chen et al. · 2016 · EMBO Molecular Medicine
  41. DNA methylation defines regional identity of human intestinal epithelial organoids and undergoes dynamic changes during development
    Judith Kraiczy, Komal Nayak, Kate J. Howell, Alexander Ross, Jessica L. Forbester, Camilla Salvestrini, Roxana C. Mustata, Sally Perkins, Amanda Andersson-Rolf, Esther Leenen et al. · 2017 · Gut
  42. In Vitro Models to Study Human Lung Development, Disease and Homeostasis.
    Alyssa J. Miller, J. Spence · 2017 · Physiology
  43. Patient-derived tumor organoids for prediction of cancer treatment response
    Peter W. Nagle, John Th. M. Plukker, Christina T. Muijs, Peter van Luijk, Robert Paul Coppes · 2018 · Seminars in Cancer Biology
  44. Efficient and Allele-Specific Genome Editing of Disease Loci in Human iPSCs
    Cory J. Smith, Leire Abalde-Atristain, Chaoxia He, Brett R. Brodsky, Evan M. Braunstein, Pooja Chaudhari, Yoon-Young Jang, Linzhao Cheng, Zhaohui Ye · 2014 · Molecular Therapy
  45. Mitochondrial replacement therapy in reproductive medicine
    Don P. Wolf, Nargiz Mitalipov, Shoukhrat M. Mitalipov · 2014 · Trends in Molecular Medicine
  46. Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications
    Fatema Safri, Romario Nguyen, Shadi Zerehpooshnesfchi, Jacob George, Liang Qiao · 2024 · Cancer Gene Therapy
  47. Stem Cells Marked by the R-Spondin Receptor LGR5
    Bon‐Kyoung Koo, Hans C. Clevers · 2014 · Gastroenterology
  48. New pharmacological approaches for cystic fibrosis: Promises, progress, pitfalls
    Scott Cameron Bell, K. De Boeck, Margarida Duarte Amaral · 2014 · Pharmacology & Therapeutics
  49. Advances in CRISPR-Cas9 genome engineering: lessons learned from RNA interference
    Rodolphe Barrangou, Amanda Birmingham, Stefan Wiemann, Roderick L. Beijersbergen, Veit Hornung, Anja van Brabant Smith · 2015 · Nucleic Acids Research
  50. A Chemically Defined Hydrogel for Human Liver Organoid Culture
    Shicheng Ye, Jochem W.B. Boeter, Marko Mihajlovic, Frank G. van Steenbeek, Monique E. van Wolferen, Loes A. Oosterhoff, Ary Marsee, Massimiliano Caiazzo, Luc J. W. van der Laan, Louis C. Penning et al. · 2020 · Advanced Functional Materials
  51. Somatic cell-derived organoids as prototypes of human epithelial tissues and diseases
    Masayuki Fujii, Toshiro Sato · 2020 · Nature Materials
  52. Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer
    Alex Handler Wagner, Siddhartha H. K. Devarakonda, Zachary L. Skidmore, Kilannin Krysiak, Avinash Ramu, Lee Trani, Jason Kunisaki, Ashiq Masood, Saiama Naheed Waqar, Nicholas C. Spies et al. · 2018 · Nature Communications
  53. USP7 Is a Tumor-Specific WNT Activator for APC-Mutated Colorectal Cancer by Mediating β-Catenin Deubiquitination
    Laura Novellasdemunt, Valentina Foglizzo, Laura Gómez-Cuadrado, Pedro Antas, Anna Kucharska, Vesela Encheva, Ambrosius P. Snijders, Vivian Sze Wing Li · 2017 · Cell Reports
  54. Establishment of human fetal hepatocyte organoids and CRISPR–Cas9-based gene knockin and knockout in organoid cultures from human liver
    Delilah F. G. Hendriks, Benedetta Artegiani, Huili Hu, Susana M. Chuva de Sousa Lopes, Hans C. Clevers · 2020 · Nature Protocols
  55. CRISPR-Cas for genome editing: Classification, mechanism, designing and applications
    Simran Kaur Bhatia, Pooja ., Sudesh Kumar Yadav · 2023 · International Journal of Biological Macromolecules
  56. Lipid nanoparticles for short interfering RNA delivery
    Leung, Alex K.K., Tam, Yuen Yi C., Cullis, Pieter R. · 2014 · Advances in genetics
  57. Generation of Genomic Deletions in Mammalian Cell Lines via CRISPR/Cas9
    Daniel E. Bauer, Matthew C. Canver, Stuart H. Orkin · 2014 · Journal of Visualized Experiments
  58. A general strategy to construct small molecule biosensors in eukaryotes
    Justin Feng, Benjamin W. Jester, Christine Elaine Tinberg, Daniel J. Mandell, Mauricio S. Antunes, Raj Chari, Kevin J. Morey, Xavier Rios, June I. Medford, George McDonald Church et al. · 2015 · eLife
  59. Concise Review: Current Status of Three-Dimensional Organoids as Preclinical Models
    Garima Kaushik, Moorthy Palanimuthu Ponnusamy, Surinder K. Batra · 2018 · Stem Cells
  60. Improved Hematopoietic Differentiation Efficiency of Gene-Corrected Beta-Thalassemia Induced Pluripotent Stem Cells by CRISPR/Cas9 System
    Bing Song, Yong Fan, Wenyin He, Detu Zhu, Xiaohua Niu, Ding Wang, Zhanhui Ou, Min Luo, Xiaofang Sun · 2014 · Stem Cells and Development
  61. CRISPR/Cas 9 genome editing and its applications in organoids
    Else Driehuis, Hans C. Clevers · 2017 · American Journal of Physiology-Gastrointestinal and Liver Physiology
  62. BRCA-deficient mouse mammary tumor organoids to study cancer-drug resistance
    Alexandra A. Duarte, Ewa Gogola, Norman Sachs, Marco Barazas, Stefano Annunziato, Julian R. de Ruiter, Arno Velds, Sohvi Blatter, Julia M. Houthuijzen, Marieke van de Ven et al. · 2017 · Nature Methods
  63. International regulatory landscape and integration of corrective genome editing into in vitro fertilization
    Araki, Motoko, Ishii, Tetsuya · 2014 · Reproductive Biology and Endocrinology
  64. Organoids as Model for Infectious Diseases: Culture of Human and Murine Stomach Organoids and Microinjection of Helicobacter Pylori
    Sina Bartfeld, Hans C. Clevers · 2015 · Journal of Visualized Experiments
  65. New and emerging targeted therapies for cystic fibrosis
    Bradley S. Quon, Steven Mark Rowe · 2016 · BMJ
  66. Gut organoids: mini-tissues in culture to study intestinal physiology and disease
    Mohammad Almeqdadi, Miyeko Mana, Jatin Roper, Ömer H. Yilmaz · 2019 · American Journal of Physiology-Cell Physiology
  67. Efficient CRISPR-Cas9-Mediated Generation of Knockin Human Pluripotent Stem Cells Lacking Undesired Mutations at the Targeted Locus
    Merkle, Florian T., Neuhausser, Werner M., Santos, David, Valen, Eivind, Gagnon, James A., Maas, Kristi, Sandoe, Jackson, Schier, Alexander F., Eggan, Kevin · 2015 · Cell Reports
  68. CRISPR-Cas9 for in vivo Gene Therapy: Promise and Hurdles
    Wei-Jing Dai, Liyao Zhu, Zhongyi Yan, Yong Xu, Qilong Wang, Xiaojie Lu · 2016 · Molecular Therapy — Nucleic Acids
  69. Future therapies for cystic fibrosis
    Lucy Allen, Lorna J Allen, S.B. Carr, Gwyneth Davies, Damian G. Downey, Marie E. Egan, Julian T. Forton, Robert D. Gray, CHARLES S. HAWORTH, Alex Robert Horsley et al. · 2023 · Nature Communications
  70. 3D Cell Cultures: Evolution of an Ancient Tool for New Applications
    Andrea Cacciamali, Riccardo Villa, Silvia Dotti · 2022 · Frontiers in Physiology
  71. Mechanisms of Pediatric Inflammatory Bowel Disease
    Joanna M. Peloquin, Gautam Goel, Eduardo J. Villablanca, Ramnik J. Xavier · 2016 · Annual Review of Immunology
  72. Nanoparticles that deliver triplex-forming peptide nucleic acid molecules correct F508del CFTR in airway epithelium
    Nicole Ali McNeer, Kavitha K. Anandalingam, Rachel J. Fields, Christina R. Caputo, Sascha Kopic, Anisha Gupta, Elias Quijano, Lee A. Polikoff, Yong Kong, Raman Bahal et al. · 2015 · Nature Communications
  73. Translational applications of adult stem cell-derived organoids
    Jarno Drost, Hans C. Clevers · 2017 · Development
  74. Modeling Human Digestive Diseases With CRISPR-Cas9–Modified Organoids
    Masayuki Fujii, Hans C. Clevers, Toshiro Sato · 2018 · Gastroenterology
  75. Organoid based personalized medicine: from bench to bedside
    Yaqi Li, Peiyuan Tang, Sanjun Cai, Junjie Peng, Guoqiang Hua · 2020 · Cell Regeneration
  76. Evaluating CRISPR-based prime editing for cancer modeling and CFTR repair in organoids
    Geurts, Maarten H, de Poel, Eyleen, Pleguezuelos-Manzano, Cayetano, Oka, Rurika, Carrillo, Léo, Andersson-Rolf, Amanda, Boretto, Matteo, Brunsveld, Jesse E, van Boxtel, Ruben, Beekman, Jeffrey M et al. · 2021 · Life Science Alliance
  77. Current Progress in Therapeutic Gene Editing for Monogenic Diseases
    Versha Prakash, Marc Moore, Rafael J. Yáñez‐Muñoz · 2016 · Molecular Therapy
  78. DNA stretching induces Cas9 off-target activity
    Matthew D. Newton, Ben Taylor, Rosalie P.C. Driessen, Leonie Roos, Nevena Cvetešić, Shenaz Allyjaun, Boris Lenhard, Maria Emanuela Cuomo, David Rueda · 2019 · Nature Structural & Molecular Biology
  79. CRISPR-Based Diagnosis of Infectious and Noninfectious Diseases
    Somayeh Jolany vangah, Camellia Katalani, Hannah A. Boone, Abbas Hajizade, Adna Sijerčić, Gholamreza Ahmadian · 2020 · Biological Procedures Online
  80. Establishment of Human Epithelial Enteroids and Colonoids from Whole Tissue and Biopsy
    Maxime M. Mahé, Nambirajan Sundaram, Carey L. Watson, Noah F. Shroyer, Michael A. Helmrath · 2015 · Journal of Visualized Experiments
  81. Delivery of Tissue-Targeted Scalpels: Opportunities and Challenges for In Vivo CRISPR/Cas-Based Genome Editing
    Tuo Wei, Qiang Cheng, Lukas Farbiak, Daniel G. Anderson, Róbert Langer, Daniel J. Siegwart · 2020 · ACS Nano
  82. Delivery and therapeutic applications of gene editing technologies ZFNs, TALENs, and CRISPR/Cas9
    Justin S. LaFountaine, Kristin Fathe, Hugh D. C. Smyth · 2015 · International Journal of Pharmaceutics
  83. High-Efficiency, Selection-free Gene Repair in Airway Stem Cells from Cystic Fibrosis Patients Rescues CFTR Function in Differentiated Epithelia
    Sriram Vaidyanathan, Ameen Abdulla Salahudeen, Zachary M. Sellers, Dawn T. Bravo, S. S. Choi, Arpit Batish, Wei Le, Ron Baik, Sean de la O, Milan P. Kaushik et al. · 2019 · Cell stem cell
  84. Gesicle-Mediated Delivery of CRISPR/Cas9 Ribonucleoprotein Complex for Inactivating the HIV Provirus
    Lee Ann Campbell, Lamarque M. Coke, Christopher T. Richie, Lowella V. Fortuno, Aaron Y. Park, Brandon K. Harvey · 2018 · Molecular Therapy
  85. Gene therapy: progress and predictions
    Mary K. Collins, Adrian James Thrasher · 2015 · Proceedings of the Royal Society B Biological Sciences
  86. Cancer Spheroids and Organoids as Novel Tools for Research and Therapy: State of the Art and Challenges to Guide Precision Medicine
    Sanae El Harane, Bochra Zidi, Nadia El Harane, Karl‐Heinz Krause, Thomas Matthes, Olivier Preynat‐Seauve · 2023 · Cells
  87. Game changers in science and technology - now and beyond
    Ulrich A. K. Betz, Loukik Arora, R.A. Assal, Hatylas F. Z de Azevedo, Jeremy Baldwin, Michael S. Becker, Stefan Bostock, Vinton W.T. Cheng, Tobias Egle, Nicola Ferrari et al. · 2023 · Technological Forecasting and Social Change
  88. Self-assembled peptide–poloxamine nanoparticles enable in vitro and in vivo genome restoration for cystic fibrosis
    Guan, Shan, Munder, Antje, Hedtfeld, Silke, Braubach, Peter, Glage, Silke, Zhang, Longgui, Lienenklaus, Stefan, Schultze, Anja, Hasenpusch, Günther, Garrels, Wiebke et al. · 2019 · Nature Nanotechnology
  89. Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis
    Tamsin R.M. Lannagan, Young K Lee, Tongtong Wang, Jatin Roper, Mark L. Bettington, Lochlan Fennell, Laura Vrbanac, Lisa Jonavicius, Roshini Somashekar, Krystyna A. Gieniec et al. · 2018 · Gut
  90. Genome editing: A perspective on the application of CRISPR/Cas9 to study human diseases (Review)
    Diana Raquel Rodríguez-Rodríguez, Ramiro Ram�rez‐Sol�s, Mario Alberto Garza‐Elizondo, Mar�a Garza‐Rodr�guez, Hugo Alberto Barrera-Saldaña · 2019 · International Journal of Molecular Medicine
  91. Responsive Nanocarriers as an Emerging Platform for Cascaded Delivery of Nucleic Acids to Cancer
    Yang Liu, Cong‐Fei Xu, Shoaib Iqbal, Xianzhu Yang, Jun Wang · 2017 · Advanced Drug Delivery Reviews
  92. Emerging trends in organ-on-a-chip systems for drug screening
    Yanping Wang, Yanfeng Gao, Yongchun Pan, Dongtao Zhou, Yuta Liu, Yi Bing Yin, Jingjing Yang, Yuzhen Wang, Yujun Song · 2023 · Acta Pharmaceutica Sinica B
  93. CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool
    Loureiro, Alexandre, da Silva, Gabriela Jorge · 2019 · Antibiotics
  94. Three-dimensional models for studying development and disease: moving on from organisms to organs-on-a-chip and organoids
    Emily Jackson, Hang Lu · 2016 · Integrative Biology
  95. Convergence of microengineering and cellular self-organization towards functional tissue manufacturing
    Jérémie Laurent, Guillaume Blin, François Chatelain, Valérie Vanneaux, Alexandra Fuchs, Jérôme Larghero, Manuel Théry · 2017 · Nature Biomedical Engineering
  96. CRISPR/Cas9‐mediated genome editing: From basic research to translational medicine
    Filipe V. Jacinto, Wolfgang Link, Bibiana I. Ferreira · 2020 · Journal of Cellular and Molecular Medicine
  97. Research Progress, Challenges, and Breakthroughs of Organoids as Disease Models
    Yisheng Huang, Zhijie Huang, Zhengming Tang, Yuanxin Chen, Mingshu Huang, Hongyu Liu, Weibo Huang, Qingsong Ye, Bo Jia · 2021 · Frontiers in Cell and Developmental Biology
  98. CRISPR/Cas9 DNA cleavage at SNP-derived PAM enables both in vitro and in vivo KRT12 mutation-specific targeting
    David Courtney, Jonathan Edward Moore, Sarah D. Atkinson, Eleonora Maurizi, Edwin H. A. Allen, Deena M. Leslie Pedrioli, W.H. Irwin McLean, M. Andrew Nesbit, Tara Moore · 2015 · Gene Therapy
  99. Emerging Therapeutic Approaches for Cystic Fibrosis. From Gene Editing to Personalized Medicine
    Iwona Maria Pranke, Anita Golec, Alexandre Hinzpeter, Aleksander Edelman, Isabelle Sermet‐Gaudelus · 2019 · Frontiers in Pharmacology
  100. Protospacer adjacent motif (PAM)-distal sequences engage CRISPR Cas9 DNA target cleavage
    Cencic, Regina, Miura, Hisashi, Malina, Abba, Robert, Francis, Ethier, Sylvain, Schmeing, T. Martin, Dostie, Josée, Pelletier, Jerry · 2014 · PLoS ONE